Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Gains from Investment Securities (2016 - 2025)

Harte Hanks has reported Gains from Investment Securities over the past 16 years, most recently at -$244000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities rose 72.62% to -$244000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 313.2% year-over-year, with the annual reading at $1.3 million for FY2025, 313.2% up from the prior year.
  • Gains from Investment Securities was -$244000.0 for Q4 2025 at Harte Hanks, down from $310000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $6.3 million in Q4 2023 and troughed at -$9.2 million in Q4 2022.
  • The 5-year median for Gains from Investment Securities is $185500.0 (2021), against an average of -$194650.0.
  • Year-over-year, Gains from Investment Securities soared 806.06% in 2021 and then tumbled 2673.26% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at -$1.1 million in 2021, then tumbled by 709.08% to -$9.2 million in 2022, then skyrocketed by 168.32% to $6.3 million in 2023, then tumbled by 114.22% to -$891000.0 in 2024, then skyrocketed by 72.62% to -$244000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Gains from Investment Securities are -$244000.0 (Q4 2025), $310000.0 (Q3 2025), and $990000.0 (Q2 2025).